U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C32H38ClN3O2
Molecular Weight 532.116
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZELIRAGON

SMILES

CCCCC1=NC(=CN1C2=CC=C(OC3=CC=C(Cl)C=C3)C=C2)C4=CC=C(OCCCN(CC)CC)C=C4

InChI

InChIKey=KJNNWYBAOPXVJY-UHFFFAOYSA-N
InChI=1S/C32H38ClN3O2/c1-4-7-9-32-34-31(25-10-16-28(17-11-25)37-23-8-22-35(5-2)6-3)24-36(32)27-14-20-30(21-15-27)38-29-18-12-26(33)13-19-29/h10-21,24H,4-9,22-23H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C32H38ClN3O2
Molecular Weight 532.116
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Azeliragon is an orally bioavailable small molecule that inhibits the receptor for advanced glycation endproducts (RAGE). RAGE has been proposed to contribute to Alzheimer's disease pathology by promoting vascular leakage, promoting influx of peripheral amyloid beta into brain, mediating amyloid beta induced oxidative stress, mediating AGE induced hyperphosphorylation of tau and amyloid beta mediated neuronal death. Azeliragon is in Phase III clinical trial for the treatment of mild Alzheimer's disease.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
AZELIRAGON

Approved Use

Unknown
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

Azeliragon 5 mg orally once daily for 2 years.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:52:26 UTC 2023
Edited
by admin
on Sat Dec 16 17:52:26 UTC 2023
Record UNII
LPU25F15UQ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZELIRAGON
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
azeliragon [INN]
Common Name English
TTP-488
Code English
1-PROPANAMINE, 3-(4-(2-BUTYL-1-(4-(4-CHLOROPHENOXY)PHENYL)-1H-IMIDAZOL-4-YL)PHENOXY)-N,N-DIETHYL-
Systematic Name English
TTP488
Code English
3-(4-{2-Butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl}phenoxy)-N,N-diethylpropan-1-amine
Systematic Name English
Azeliragon [WHO-DD]
Common Name English
AZELIRAGON [USAN]
Common Name English
PF-04494700
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 915922
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C174675
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
CAS
603148-36-3
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
DRUG BANK
DB12689
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
EPA CompTox
DTXSID601117468
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
SMS_ID
300000034093
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
PUBCHEM
11180124
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
CAS
1421852-66-5
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
NO STRUCTURE GIVEN
FDA UNII
LPU25F15UQ
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
USAN
DE-169
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
INN
9945
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
PRIMARY
CAS
1263796-37-7
Created by admin on Sat Dec 16 17:52:26 UTC 2023 , Edited by admin on Sat Dec 16 17:52:26 UTC 2023
NO STRUCTURE GIVEN
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY